{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T12:39:20Z","timestamp":1766839160458,"version":"3.48.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,27]]},"DOI":"10.7759\/cureus.100174","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T12:37:18Z","timestamp":1766839038000},"source":"Crossref","is-referenced-by-count":0,"title":["Recurrent Intracranial Atherosclerotic Disease (ICAD)-Large-Vessel Occlusion (LVO) in Acute Lymphoblastic Leukemia Treated by Rescue Angioplasty: A Case Report"],"prefix":"10.7759","author":[{"given":"Ryunosuke","family":"Yoshihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Ishizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Okuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsushi","family":"Hatayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohiko","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.743211","article-title":"Secular trends in the incidence of and risk factors for ischemic stroke and its subtypes in Japanese population","volume":"118","author":"Kubo M","year":"2008","unstructured":"Kubo M, Hata J, Doi Y, Tanizaki Y, Iida M, Kiyohara Y. Secular trends in the incidence of and risk factors for ischemic stroke and its subtypes in Japanese population. Circulation. 2008, 118:2672-8. 10.1161\/CIRCULATIONAHA.107.743211","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.118.023996","article-title":"WEAVE trial: final results in 152 on-label patients","volume":"50","author":"Alexander MJ","year":"2019","unstructured":"Alexander MJ, Zauner A, Chaloupka JC, et al.. WEAVE trial: final results in 152 on-label patients. Stroke. 2019, 50:889-94. 10.1161\/STROKEAHA.118.023996","journal-title":"Stroke"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.12000","article-title":"Effect of stenting plus medical therapy vs medical therapy alone on risk of stroke and death in patients with symptomatic intracranial stenosis: the CASSISS randomized clinical trial","volume":"328","author":"Gao P","year":"2022","unstructured":"Gao P, Wang T, Wang D, et al.. Effect of stenting plus medical therapy vs medical therapy alone on risk of stroke and death in patients with symptomatic intracranial stenosis: the CASSISS randomized clinical trial. JAMA. 2022, 328:534-42. 10.1001\/jama.2022.12000","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.12829","article-title":"Balloon angioplasty vs medical management for intracranial artery stenosis: the BASIS randomized clinical trial","volume":"332","author":"Sun X","year":"2024","unstructured":"Sun X, Deng Y, Zhang Y, et al.. Balloon angioplasty vs medical management for intracranial artery stenosis: the BASIS randomized clinical trial. JAMA. 2024, 332:1059-69. 10.1001\/jama.2024.12829","journal-title":"JAMA"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1771270","article-title":"Ischemic stroke in cancer: mechanisms, biomarkers, and implications for treatment","volume":"50","author":"Costamagna G","year":"2024","unstructured":"Costamagna G, Navi BB, Beyeler M, Hottinger AF, Alberio L, Michel P. Ischemic stroke in cancer: mechanisms, biomarkers, and implications for treatment. Semin Thromb Hemost. 2024, 50:342-59. 10.1055\/s-0043-1771270","journal-title":"Semin Thromb Hemost"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-012-0250-3","article-title":"Intracranial hemorrhage in patients with cancer","volume":"14","author":"Velander AJ","year":"2012","unstructured":"Velander AJ, DeAngelis LM, Navi BB. Intracranial hemorrhage in patients with cancer. Curr Atheroscler Rep. 2012, 14:373-81. 10.1007\/s11883-012-0250-3","journal-title":"Curr Atheroscler Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-016-0117-x","article-title":"Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis","volume":"14","author":"Asakura H","year":"2016","unstructured":"Asakura H, Takahashi H, Uchiyama T, et al.. Proposal for new diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis. Thromb J. 2016, 14:42. 10.1186\/s12959-016-0117-x","journal-title":"Thromb J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000201208","article-title":"Investigating outcomes post-endovascular thrombectomy in acute stroke patients with cancer","volume":"99","author":"Shapiro SD","year":"2022","unstructured":"Shapiro SD, Vazquez S, Das A, et al.. Investigating outcomes post-endovascular thrombectomy in acute stroke patients with cancer. Neurology. 2022, 99:e2583-92. 10.1212\/WNL.0000000000201208","journal-title":"Neurology"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10110441","article-title":"Impacts of cancer on platelet production, activation and education and mechanisms of cancer-associated thrombosis","volume":"10","author":"Plantureux L","year":"2018","unstructured":"Plantureux L, M\u00e8ge D, Crescence L, Dignat-George F, Dubois C, Panicot-Dubois L. Impacts of cancer on platelet production, activation and education and mechanisms of cancer-associated thrombosis. Cancers (Basel). 2018, 10:441. 10.3390\/cancers10110441","journal-title":"Cancers (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01467.x","article-title":"The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment","volume":"3","author":"De Stefano V","year":"2005","unstructured":"De Stefano V, Sor\u00e0 F, Rossi E, et al.. The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment. J Thromb Haemost. 2005, 3:1985-92. 10.1111\/j.1538-7836.2005.01467.x","journal-title":"J Thromb Haemost"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050399","article-title":"Disseminated intravascular coagulation in acute lymphoblastic leukemia at presentation and in early phase of remission induction therapy","volume":"76","author":"Higuchi T","year":"1998","unstructured":"Higuchi T, Mori H, Niikura H, Omine M, Okada S, Terada H. Disseminated intravascular coagulation in acute lymphoblastic leukemia at presentation and in early phase of remission induction therapy. Ann Hematol. 1998, 76:263-9. 10.1007\/s002770050399","journal-title":"Ann Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.260935","article-title":"A multicenter total therapy strategy for de novo adult Philadelphia chromosome positive acute lymphoblastic leukemia patients: final results of the GIMEMA LAL1509 protocol","volume":"106","author":"Chiaretti S","year":"2021","unstructured":"Chiaretti S, Ansuinelli M, Vitale A, et al.. A multicenter total therapy strategy for de novo adult Philadelphia chromosome positive acute lymphoblastic leukemia patients: final results of the GIMEMA LAL1509 protocol. Haematologica. 2021, 106:1828-38. 10.3324\/haematol.2020.260935","journal-title":"Haematologica"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58101495","article-title":"Adverse reaction profiles related to gastrointestinal bleeding events associated with BCR-ABL tyrosine kinase inhibitors","volume":"58","author":"Kawada K","year":"2022","unstructured":"Kawada K, Ishida T, Jobu K, et al.. Adverse reaction profiles related to gastrointestinal bleeding events associated with BCR-ABL tyrosine kinase inhibitors. Medicina (Kaunas). 2022, 58:1495. 10.3390\/medicina58101495","journal-title":"Medicina (Kaunas)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3171\/2022.12.JNS222152","article-title":"Failed mechanical thrombectomy: prevalence, etiology, and predictors","volume":"139","author":"Lajthia O","year":"2023","unstructured":"Lajthia O, Almallouhi E, Ali H, et al.. Failed mechanical thrombectomy: prevalence, etiology, and predictors. J Neurosurg. 2023, 139:714-20. 10.3171\/2022.12.JNS222152","journal-title":"J Neurosurg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.024889","article-title":"Thrombectomy outcomes of intracranial atherosclerosis-related occlusions","volume":"50","author":"Tsang AC","year":"2019","unstructured":"Tsang AC, Orru E, Klostranec JM, et al.. Thrombectomy outcomes of intracranial atherosclerosis-related occlusions. Stroke. 2019, 50:1460-6. 10.1161\/STROKEAHA.119.024889","journal-title":"Stroke"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/443509-recurrent-intracranial-atherosclerotic-disease-icad-large-vessel-occlusion-lvo-in-acute-lymphoblastic-leukemia-treated-by-rescue-angioplasty-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T12:37:19Z","timestamp":1766839039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/443509-recurrent-intracranial-atherosclerotic-disease-icad-large-vessel-occlusion-lvo-in-acute-lymphoblastic-leukemia-treated-by-rescue-angioplasty-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.100174","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,27]]}}}